GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.00, $0.04 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $191.8 million versus the consensus estimate of $185.36 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q3 2022 revenue of $185 million, versus the consensus of $201 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.